170 related articles for article (PubMed ID: 10523588)
1. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.
Rowen JL; Tate JM; Nordoff N; Passarell L; McGinnis MR
J Clin Microbiol; 1999 Nov; 37(11):3735-7. PubMed ID: 10523588
[TBL] [Abstract][Full Text] [Related]
2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole disk diffusion susceptibility testing of Candida species.
Kirkpatrick WR; Turner TM; Fothergill AW; McCarthy DI; Redding SW; Rinaldi MG; Patterson TF
J Clin Microbiol; 1998 Nov; 36(11):3429-32. PubMed ID: 9774615
[TBL] [Abstract][Full Text] [Related]
5. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Wang JL; Chang SC; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].
Ruhnke M; Schmidt-Westhausen A; Trautmann M
Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745
[TBL] [Abstract][Full Text] [Related]
7. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Silva V; Alvarado D; Diaz MC
Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
[TBL] [Abstract][Full Text] [Related]
10. Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.
Baran J; Klauber E; Barczak J; Riederer K; Khatib R
J Clin Microbiol; 2000 Feb; 38(2):870-1. PubMed ID: 10655402
[TBL] [Abstract][Full Text] [Related]
11. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
[TBL] [Abstract][Full Text] [Related]
13. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
14. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
15. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
16. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
18. Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
Hrabovský V; Takáčová V; Schréterová E; Pastvová L; Hrabovská Z; Čurová K; Siegfried L
Folia Microbiol (Praha); 2017 Nov; 62(6):525-530. PubMed ID: 28361459
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
